{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T06:07:41Z","timestamp":1757311661722,"version":"3.37.3"},"reference-count":41,"publisher":"BMJ","issue":"11","license":[{"start":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T00:00:00Z","timestamp":1700352000000},"content-version":"unspecified","delay-in-days":18,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004431","name":"Fondation de France","doi-asserted-by":"publisher","award":["Edouard et Lucie Chaffoteaux award (7th edition)"],"award-info":[{"award-number":["Edouard et Lucie Chaffoteaux award (7th edition)"]}],"id":[{"id":"10.13039\/501100004431","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002661","name":"Fonds De La Recherche Scientifique - FNRS","doi-asserted-by":"publisher","award":["Postdoctoral researcher grant (FC23595)"],"award-info":[{"award-number":["Postdoctoral researcher grant (FC23595)"]}],"id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>In older adults with type 2 diabetes (T2D), overtreatment with hypoglycaemic drugs (HDs: sulfonylureas, glinides and\/or insulins) is frequent and associated with increased 1-year mortality. Deintensification of HD is thus a key issue, for which evidence is though limited. The primary objective of this study will be to estimate the effect of deintensifying HD on clinical outcomes (hospital admission or death) within 3 months in older adults (\u226575 years) with T2D.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We will emulate with real-world data a target trial, within The Health Improvement Network cohort, a large-scale database of data collected from electronic medical records of 2000 general practitioners in France. From 1 January 2010 to 28 February 2019, we will include eligible patients \u226575 years who will have T2D, a stable dose of HDs, glycated haemoglobin A1c (HbA1c) value &lt;75\u2009mmol\/mol (9.0%) and no deintensification in the past year. The target trial will be sequentially emulated (ie, eligibility assessed) every month in the database. Patients will be classified at baseline of each sequential trial in the intervention arm (deintensification of HDs: decrease of \u226550% in the total dose of HDs, including complete cessation) or control arm (no deintensification of HDs). The pooled dataset for all sequential emulated trials will be analysed. The primary outcome will be time to first occurrence of hospital admission or death, within 3 months. Secondary outcomes will be hospitalisation, death, appropriateness of glycaemic control and occurrence of HbA1c &gt;75\u2009mmol\/mol within 1\u2009year. Participants will be followed from baseline to 12 months after randomisation, administrative censoring, or death, whichever occurs first. A pooled logistic regression will be used to estimate the treatment effect on the incidence of the outcomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Dissemination and ethics<\/jats:title><jats:p>No ethical approval is needed for using retrospectively this fully anonymised database. The results will be disseminated during conferences and through publications in scientific journals.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bmjopen-2023-073081","type":"journal-article","created":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T07:15:36Z","timestamp":1700464536000},"page":"e073081","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of deintensifying hypoglycaemic drugs in older adults with type 2 diabetes: protocol for an emulation of a target trial"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4132-7769","authenticated-orcid":false,"given":"Antoine","family":"Christiaens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"No\u00e9mie","family":"Simon-Tillaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wade","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan J.","family":"Sinclair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0389-8093","authenticated-orcid":false,"given":"S\u00e9verine","family":"Henrard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5857-3085","authenticated-orcid":false,"given":"Benoit B.","family":"Boland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yannis","family":"Slaouti-J\u00e9gou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e9ranger","family":"Lekens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Bonnet-Zamponi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Tubach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lor\u00e8ne","family":"Zerah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,11,19]]},"reference":[{"key":"2023111923151774000_13.11.e073081.1","doi-asserted-by":"crossref","unstructured":"Sinclair A , Saeedi P , Kaundal A , et al . Diabetes and global ageing among 65-99-year-old adults: findings from the International diabetes Federation diabetes Atlas, 9Th edition. Diabetes Res Clin Pract 2020;162:108078. doi:10.1016\/j.diabres.2020.108078","DOI":"10.1016\/j.diabres.2020.108078"},{"key":"2023111923151774000_13.11.e073081.2","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-1801"},{"key":"2023111923151774000_13.11.e073081.3","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1001\/jamainternmed.2013.12956","article-title":"Rates of complications and mortality in older patients with diabetes mellitus: the diabetes and aging study","volume":"174","author":"Huang","year":"2014","journal-title":"JAMA Intern Med"},{"key":"2023111923151774000_13.11.e073081.4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.1989.tb01237.x"},{"key":"2023111923151774000_13.11.e073081.5","doi-asserted-by":"publisher","DOI":"10.2337\/dci19-0066"},{"key":"2023111923151774000_13.11.e073081.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1003795"},{"key":"2023111923151774000_13.11.e073081.7","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp09X394860"},{"key":"2023111923151774000_13.11.e073081.8","doi-asserted-by":"crossref","first-page":"156","DOI":"10.14336\/AD.2014.0330","article-title":"Hypoglycemia in older people - a less well recognized risk factor for frailty","volume":"6","author":"Abdelhafiz","year":"2015","journal-title":"Aging Dis"},{"key":"2023111923151774000_13.11.e073081.9","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1111\/dom.13469","article-title":"Glycaemic control and mortality in older people with type 2 diabetes: the Fremantle diabetes study phase II","volume":"20","author":"Bruce","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"2023111923151774000_13.11.e073081.10","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1093\/ageing\/afab157","article-title":"Individualisation of Glycaemic management in older people with type 2 diabetes: a systematic review of clinical practice guidelines recommendations","volume":"50","author":"Christiaens","year":"2021","journal-title":"Age Ageing"},{"key":"2023111923151774000_13.11.e073081.11","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.2337\/dc21-2116","article-title":"Effect of Deintensifying diabetes medications on negative events in older veteran nursing home residents","volume":"45","author":"Niznik","year":"2022","journal-title":"Diabetes Care"},{"key":"2023111923151774000_13.11.e073081.12","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jamda.2022.12.018","article-title":"Deprescribing glucose-lowering therapy in older adults with diabetes: a systematic review of recommendations","volume":"24","author":"Christiaens","year":"2023","journal-title":"J Am Med Dir Assoc"},{"key":"2023111923151774000_13.11.e073081.13","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1007\/s40520-023-02519-3","article-title":"Essential steps in primary care management of older people with type 2 diabetes: an executive summary on behalf of the European geriatric medicine society (Eugms) and the European diabetes working party for older people (EDWPOP) collaboration","volume":"35","author":"Bourdel-Marchasson","year":"2023","journal-title":"Aging Clin Exp Res"},{"key":"2023111923151774000_13.11.e073081.14","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2019-00198"},{"issue":"Suppl 1","key":"2023111923151774000_13.11.e073081.15","first-page":"S195","article-title":"13. older adults: standards of medical care in Diabetes-2022","volume":"45","year":"2022","journal-title":"Diabetes Care"},{"key":"2023111923151774000_13.11.e073081.16","doi-asserted-by":"crossref","first-page":"S283","DOI":"10.1016\/j.jcjd.2017.10.021","article-title":"Diabetes in older people","volume":"42 Suppl 1","author":"Meneilly","year":"2018","journal-title":"Can J Diabetes"},{"key":"2023111923151774000_13.11.e073081.17","first-page":"832","article-title":"Deprescribing Antihyperglycemic agents in older persons: evidence-based clinical practice guideline","volume":"63","author":"Farrell","year":"2017","journal-title":"Can Fam Physician"},{"key":"2023111923151774000_13.11.e073081.18","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S2213-8587(20)30230-8","article-title":"Diabetes in ageing: pathways for developing the evidence base for clinical guidance","volume":"8","author":"Munshi","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2023111923151774000_13.11.e073081.19","first-page":"1896","article-title":"Managing older people with diabetes-we need better evidence with wise interpretation!","volume":"50","author":"Sinclair","year":"2021","journal-title":"Age Ageing"},{"key":"2023111923151774000_13.11.e073081.20","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jcjd.2022.01.009","article-title":"Benefits and harms of Deprescribing Antihyperglycemics for adults with type 2 diabetes: A systematic review","volume":"46","author":"Deng","year":"2022","journal-title":"Can J Diabetes"},{"key":"2023111923151774000_13.11.e073081.21","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwv254"},{"key":"2023111923151774000_13.11.e073081.22"},{"key":"2023111923151774000_13.11.e073081.23","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1016\/j.sapharm.2021.05.007","article-title":"Methods for evaluating the benefit and harms of Deprescribing in observational research using routinely collected data","volume":"18","author":"Moriarty","year":"2022","journal-title":"Res Social Adm Pharm"},{"key":"2023111923151774000_13.11.e073081.24","doi-asserted-by":"publisher","DOI":"10.1136\/jech.2002.006361"},{"key":"2023111923151774000_13.11.e073081.25","doi-asserted-by":"publisher","DOI":"10.1136\/jech.2004.029496"},{"key":"2023111923151774000_13.11.e073081.26","doi-asserted-by":"publisher","DOI":"10.14236\/jhi.v19i4.820"},{"key":"2023111923151774000_13.11.e073081.27","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1335"},{"key":"2023111923151774000_13.11.e073081.28","unstructured":"Institut national de la statistique et des \u00e9tudes \u00e9conomiques (INSEE), Available: https:\/\/www.insee.fr\/2022"},{"key":"2023111923151774000_13.11.e073081.29","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology . Guidelines for ATC classification and DDD Assignment 2018. Oslo, Norway, 2017."},{"key":"2023111923151774000_13.11.e073081.30","doi-asserted-by":"crossref","unstructured":"Christiaens A , Boland B , Germanidis M , et al . Poor health status, inappropriate glucose-lowering therapy and high one-year mortality in geriatric patients with type 2 diabetes. BMC Geriatr 2020;20:367. doi:10.1186\/s12877-020-01780-9","DOI":"10.1186\/s12877-020-01780-9"},{"key":"2023111923151774000_13.11.e073081.31","doi-asserted-by":"crossref","unstructured":"Christiaens A , Baretella O , Del Giovane C , et al . Association between diabetes Overtreatment in older Multimorbid patients and clinical outcomes: an ancillary European Multicentre study. Age Ageing 2023;52:afac320. doi:10.1093\/ageing\/afac320","DOI":"10.1093\/ageing\/afac320"},{"key":"2023111923151774000_13.11.e073081.32","doi-asserted-by":"crossref","unstructured":"Christiaens A , Hermans MP , Boland B , et al . Distinction of Cardiometabolic profiles among people \u226575\u2009years with type 2 diabetes: a latent profile analysis. BMC Endocr Disord 2019;19:85. doi:10.1186\/s12902-019-0411-2","DOI":"10.1186\/s12902-019-0411-2"},{"key":"2023111923151774000_13.11.e073081.33","doi-asserted-by":"crossref","unstructured":"Cigolle CT , Blaum CS , Lyu C , et al . Associations of age at diagnosis and duration of diabetes with morbidity and mortality among older adults. JAMA Netw Open 2022;5:e2232766. doi:10.1001\/jamanetworkopen.2022.32766","DOI":"10.1001\/jamanetworkopen.2022.32766"},{"key":"2023111923151774000_13.11.e073081.34","doi-asserted-by":"crossref","unstructured":"Christiaens A , Henrard S , Boland B , et al . Overtreatment of older people with type 2 diabetes-a high impact frequent occurrence in need of a new definition. Diabet Med 2023;40:e14994. doi:10.1111\/dme.14994","DOI":"10.1111\/dme.14994"},{"key":"2023111923151774000_13.11.e073081.35","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(87)90171-8"},{"key":"2023111923151774000_13.11.e073081.36","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/MLR.0000000000000729","article-title":"Development of a claims-based frailty indicator anchored to a well-established frailty phenotype","volume":"55","author":"Segal","year":"2017","journal-title":"Med Care"},{"key":"2023111923151774000_13.11.e073081.37","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1093\/aje\/kwx257","article-title":"External validation of the claims-based frailty index in the national health and aging trends study cohort","volume":"186","author":"Segal","year":"2017","journal-title":"Am J Epidemiol"},{"key":"2023111923151774000_13.11.e073081.38","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0597-x"},{"key":"2023111923151774000_13.11.e073081.39","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4780091214"},{"key":"2023111923151774000_13.11.e073081.40","doi-asserted-by":"publisher","DOI":"10.7326\/M16-2607"},{"key":"2023111923151774000_13.11.e073081.41","doi-asserted-by":"crossref","unstructured":"Langan SM , Schmidt SA , Wing K , et al . The reporting of studies conducted using observational routinely collected health data statement for Pharmacoepidemiology (RECORD-PE). BMJ 2018;363:k3532. doi:10.1136\/bmj.k3532","DOI":"10.1136\/bmj.k3532"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2023-073081","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T07:15:51Z","timestamp":1700464551000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2023-073081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":41,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,11,19]]},"published-print":{"date-parts":[[2023,11]]}},"alternative-id":["10.1136\/bmjopen-2023-073081"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2023-073081","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"type":"print","value":"2044-6055"},{"type":"electronic","value":"2044-6055"}],"subject":[],"published":{"date-parts":[[2023,11]]}}}